Nervous System Diseases clinical trials at University of California Health

• EDS in Ataxia Telangiectasia Patients

  open to eligible people ages 6 years and up

  This is an international, multi-center, one-year, randomized, prospective, double-blind, placebo-controlled, phase III study, designed to assess the effect of two non-overlapping dose ranges of EDS EP, administered by IV infusion once per month, on neurological symptoms of patients with Ataxia Telangiectasia.

  at UCLA

• Human Epilepsy Project 2: Resistant Focal Seizures Study

  Sorry, in progress, not accepting new patients

  The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.

  at UCSF

• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

  Sorry, in progress, not accepting new patients

  This study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.

  at UC Davis UCSF

• Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

  Sorry, in progress, not accepting new patients

  Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.

  at UCSF

Last updated: July 12, 2021